2012
4 December 2012
Late-stage pipeline review
 |
Sir Andrew Witty (CEO), Dr Moncef Slaoui (Chairman of R&D) and Dr Patrick Vallance (President of Pharmaceutical R&D) together with senior R&D leaders hosted a seminar focusing on GSK’s late stage pipeline. The event brought together the progress made in 2012, as Phase III programmes for a significant number of potential new drugs have concluded. It also provided an overview of our progress on our returns driven strategy in R&D and the sustainability of our pipeline.
|
Watch the webcast
View the presentation slides (PDF)
5 November 2012
Annual Pharmaceutical Regulatory and Compliance Congress
 |
Deidre Connolly, President North America Pharmaceuticals, spoke at the 13th Annual Pharmaceutical Regulatory and Compliance Congress about how we conduct our business.
|
Read Deidre Connolly's speech (PDF)
1 October 2012
Investor Meeting at ESMO, Vienna
 |
Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the European Society for Medical Oncology.
|
View PDF of ESMO presentation slides
Download - audio recording of the ESMO presentation (WMA file)
4 September 2012
Investor Meeting at ERS, Vienna
 |
Darrell Baker, SVP Respiratory Portfolio Optimisation Leader hosted an investor event in conjunction with data presented at the European Respiratory Society Conference. |
Download - audio recording of the teleconference (WMA file)
View PDF of ERS presentation slides
27 July 2012
Investor Meeting at IAC, Washington
 |
ViiV Healthcare Chairman David Redfern, CEO Dominique Limet and Chief Scientific and Medical Officer, John Pottage, hosted an investor event at the International AIDS Conference (IAC). |
Download - audio recording of the IAC Investor Meeting (WAV file)
View PDF of IAC presentation slides
9 June 2012
Investor Meeting at ADA, Philadelphia
 |
Dr Carlo Russo, Senior Vice President and Head of Albiglutide Development hosted an investor event in conjunction with data presented at the American Diabetes Association meeting. |
View PDF of ADA presentation slides
4 June 2012
Investor Meeting at ASCO, Chicago
|
Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the American Society of Clinical Oncology (ASCO) meeting. |
View PDF of ASCO presentation slides
15 May 2012
World Affairs Council, Philadelphia
 |
Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at the World Affairs Council (WAC) in Philadelphia about how the challenges and opportunities facing the pharmaceutical business. |
Deirdre Connelly’s WAC speech (PDF)
29 March 2012
R&D Seminar
|
Moncef Slaoui, Chairman of Research & Development and Patrick Vallance, President, Pharmaceuticals R&D, presented a live webcast - Capital Allocation in R&D and a DPU Deep Dive. |
View archived R&D Seminar webcast
View PDF of R&D Seminar presentation slides
21 March 2012
PharmEHR Summit, Philadelphia
|
Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at PharmEHR Summit in Philadelphia about how GSK sees healthcare evolving and how electronic health records fit into that shifting landscape. |
Deirdre Connelly’s PharmEHR Summit speech (PDF)
10 January 2012
Annual JP Morgan Healthcare Conference
 |
Simon Dingemans, Chief Financial Officer, gave a presentation at the 30th Annual JP Morgan Healthcare Conference in San Francisco. Simon provided an overview of the progress being made in implementing GSK’s strategy. |
View archived webcast of Simon Dingemans' presentation
Simon Dingemans' JP Morgan presentation (PDF)